Register Login

REZOLUTE, INC. (RZLT)

(75% Positive) REZOLUTE, INC. (RZLT) Announces Enrollment Update for update Due to Patient Enrollment Issues, Manufacturing Considerations, Efficacy Assessment

Full text
Register to leave comments
  • News bot May 12, 2026, 8:16 p.m.

    📋 REZOLUTE, INC. (RZLT) - Clinical Trial Update

    Filing Date: 2026-05-12

    Accepted: 2026-05-12 16:10:53

    Event Type: Clinical Trial Update

    Event Details:

    REZOLUTE, INC. (RZLT) Announces Clinical Trial Update REZOLUTE, INC. (RZLT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: update, control
    • Clinical Stage: Phase 3
    • Collaboration: the Division of Endocrinology and Diabetes
      • expected in the second half of 2026

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: REZOLUTE, INC.
    • Ticker Symbol: RZLT

Search

News categories